Focused on Addressing Critical
Unmet Needs
Based on research conducted at Baylor College of Medicine, Diakonos has been privileged to work with other leading cancer institutions such as MD Anderson and UTHealth Houston.
Diakonos Oncology
Team
Mike Wicks, MS
Chief Executive Officer
Dan Faust, PharmD
Chairman
Will Decker, PhD
Chief Science Officer
Matt Halpert, PhD
Chief Technology Officer
Jay Hartenbach, MEM
Chief Operating Officer
Ian Bellayr, PhD
Chief Regulatory Officer
Moya Daniels
Chief Quality Officer
Marcus Gohlke, CPA
Finance Director
Vanaja Konduri, PhD
VP of Research
Deancy Ocoebor
Clinical Trial Manager
David McWilliams, MBA
Advisor
Andrew Nat, MBA
Advisor